Niklas Gebauer

30PUBLICATIONS
94CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursPredictive and prognostic markersMolecular targetsMedical molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (30)

|Oct 27, 2026
PemToxTrial: An Observational Study of PEMetrexed-Associated Severe HematoTOXicity in Lung Adenocarcinoma with Bone Metastases.

|Sep 18, 2026
Loncastuximab tesirine in heavily pretreated patients with large B-cell lymphoma: a German Lymphoma Alliance analysis.

|May 13, 2026
Prognostic Value of Regnase-1 in High-Grade Soft Tissue Sarcoma: Favourable in UPS, Yet Inverted in Adjuvantly Irradiated Patients.

|Apr 14, 2026
Adenosine Pathway Activation Defines Genetically Linked Immunosuppressive Subtypes in Solid Tumor Brain Metastases.

Arthur Bauer, Annette Arndt, Luisa Reichenbach

|Jun 26, 2025
Downregulation of S6 Kinase and Hedgehog-Gli1 by Inhibition of Fatty Acid Synthase in AML with FLT3-ITD Mutation.

Maxim Kebenko, Ruimeng Zhuang, Konstantin Hoffer

|Apr 24, 2025
Ruxolitinib mediated paradoxical JAK2 hyperphosphorylation is due to the protection of activation loop tyrosines from phosphatases.

Sivahari P Gorantla, Lorenz Oelschläger, Gerin Prince

Pageof 5

Frequent Collaborators

19 joint publications

Hanno Witte

13 joint publications

Nikolas von Bubnoff

8 joint publications

Axel Künstner

8 joint publications

Hauke Busch